Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1465 to 1475 of 1475 entries
Sorted by: Best Match Show Resources per page
Spatial Technology Assessment of Green Space Exposure and Myopia.

Ophthalmology

Yang Y, Chen W, Xu A, Zhao L, Ding X, Li J, Zhu Y, Chen C, Long E, Liu Z, Wang X, Li X, Zhang X, Jiang Z, He H, Wang G, Jin L, Liao H, Yun D, Yu-Wai-Man P, Yan P, Wang R, Li Z, Xie Y, Liu Y, Wang X, Zhang Q, Wang J, Nie D, Zhang S, Ting DSW, Wong TY, He M, Liu Y, Morgan IG, Lin H.
PMID: 34352303
Ophthalmology. 2022 Jan;129(1):113-117. doi: 10.1016/j.ophtha.2021.07.031. Epub 2021 Aug 02.

No abstract available.

Cite
Yang Y, Chen W, Xu A, et al. Spatial Technology Assessment of Green Space Exposure and Myopia. Ophthalmology. 2021;129(1):113-117doi: 10.1016/j.ophtha.2021.07.031.
Yang, Y., Chen, W., Xu, A., Zhao, L., Ding, X., Li, J., Zhu, Y., Chen, C., Long, E., Liu, Z., Wang, X., Li, X., Zhang, X., Jiang, Z., He, H., Wang, G., Jin, L., Liao, H., Yun, D., Yu-Wai-Man, P., Yan, P., Wang, R., Li, Z., Xie, Y., Liu, Y., Wang, X., Zhang, Q., Wang, J., Nie, D., Zhang, S., Ting, D. S. W., Wong, T. Y., He, M., Liu, Y., Morgan, I. G., & Lin, H. (2022). Spatial Technology Assessment of Green Space Exposure and Myopia. Ophthalmology, 129(1), 113-117. https://doi.org/10.1016/j.ophtha.2021.07.031
Yang, Yahan, et al. "Spatial Technology Assessment of Green Space Exposure and Myopia." Ophthalmology vol. 129,1 (2022): 113-117. doi: https://doi.org/10.1016/j.ophtha.2021.07.031
Yang Y, Chen W, Xu A, Zhao L, Ding X, Li J, Zhu Y, Chen C, Long E, Liu Z, Wang X, Li X, Zhang X, Jiang Z, He H, Wang G, Jin L, Liao H, Yun D, Yu-Wai-Man P, Yan P, Wang R, Li Z, Xie Y, Liu Y, Wang X, Zhang Q, Wang J, Nie D, Zhang S, Ting DSW, Wong TY, He M, Liu Y, Morgan IG, Lin H. Spatial Technology Assessment of Green Space Exposure and Myopia. Ophthalmology. 2022 Jan;129(1):113-117. doi: 10.1016/j.ophtha.2021.07.031. Epub 2021 Aug 02. PMID: 34352303.
Copy Download .nbib Format: NLM
A Reconfigurable Differential-to-Single-Ended Autonomous Current Adaptation Buffer Amplifier Suitable for Biomedical Applications.

IEEE transactions on biomedical circuits and systems

Lo ZJ, Wang YC, Huang YJ, Hung RY, Wu YH, Wang TY, Huang YJ, Huang HC, Lu YC, Peng SY, Chang CY, Lai WS, Hsu YJ.
PMID: 34919521
IEEE Trans Biomed Circuits Syst. 2021 Dec 17; doi: 10.1109/TBCAS.2021.3136248. Epub 2021 Dec 17.

A reconfigurable differential-to-single-ended autonomous current adaptation buffer amplifier (ACABA) suitable for biomedical applications is proposed. The ACABA, based on floating-gate technologies, is a capacitive circuit, of which output DC level and bandwidth can be adjusted by programming charges on...

Cite
Lo ZJ, Wang YC, Huang YJ, et al. A Reconfigurable Differential-to-Single-Ended Autonomous Current Adaptation Buffer Amplifier Suitable for Biomedical Applications. IEEE Trans Biomed Circuits Syst. 2021;doi: 10.1109/TBCAS.2021.3136248.
Lo, Z. J., Wang, Y. C., Huang, Y. J., Hung, R. Y., Wu, Y. H., Wang, T. Y., Huang, Y. J., Huang, H. C., Lu, Y. C., Peng, S. Y., Chang, C. Y., Lai, W. S., & Hsu, Y. J. (2021). A Reconfigurable Differential-to-Single-Ended Autonomous Current Adaptation Buffer Amplifier Suitable for Biomedical Applications. IEEE transactions on biomedical circuits and systems, . https://doi.org/10.1109/TBCAS.2021.3136248
Lo, Zu-Jia, et al. "A Reconfigurable Differential-to-Single-Ended Autonomous Current Adaptation Buffer Amplifier Suitable for Biomedical Applications." IEEE transactions on biomedical circuits and systems vol. (2021). doi: https://doi.org/10.1109/TBCAS.2021.3136248
Lo ZJ, Wang YC, Huang YJ, Hung RY, Wu YH, Wang TY, Huang YJ, Huang HC, Lu YC, Peng SY, Chang CY, Lai WS, Hsu YJ. A Reconfigurable Differential-to-Single-Ended Autonomous Current Adaptation Buffer Amplifier Suitable for Biomedical Applications. IEEE Trans Biomed Circuits Syst. 2021 Dec 17; doi: 10.1109/TBCAS.2021.3136248. Epub 2021 Dec 17. PMID: 34919521.
Copy Download .nbib Format: NLM
Advances of Glycometabolism Engineering in Chinese Hamster Ovary Cells.

Frontiers in bioengineering and biotechnology

Zhang HY, Fan ZL, Wang TY.
PMID: 34926421
Front Bioeng Biotechnol. 2021 Dec 02;9:774175. doi: 10.3389/fbioe.2021.774175. eCollection 2021.

As the most widely used mammalian cell line, Chinese hamster ovary (CHO) cells can express various recombinant proteins with a post translational modification pattern similar to that of the proteins from human cells. During industrial production, cells need large...

Cite
Zhang HY, Fan ZL, Wang TY. Advances of Glycometabolism Engineering in Chinese Hamster Ovary Cells. Front Bioeng Biotechnol. 2021;9:774175doi: 10.3389/fbioe.2021.774175.
Zhang, H. Y., Fan, Z. L., & Wang, T. Y. (2021). Advances of Glycometabolism Engineering in Chinese Hamster Ovary Cells. Frontiers in bioengineering and biotechnology, 9774175. https://doi.org/10.3389/fbioe.2021.774175
Zhang, Huan-Yu, et al. "Advances of Glycometabolism Engineering in Chinese Hamster Ovary Cells." Frontiers in bioengineering and biotechnology vol. 9 (2021): 774175. doi: https://doi.org/10.3389/fbioe.2021.774175
Zhang HY, Fan ZL, Wang TY. Advances of Glycometabolism Engineering in Chinese Hamster Ovary Cells. Front Bioeng Biotechnol. 2021 Dec 02;9:774175. doi: 10.3389/fbioe.2021.774175. eCollection 2021. PMID: 34926421; PMCID: PMC8675083.
Copy Download .nbib Format: NLM
OPTICAL COHERENCE TOMOGRAPHY FEATURES OF POLYPOIDAL LESION CLOSURE IN POLYPOIDAL CHOROIDAL VASCULOPATHY TREATED WITH AFLIBERCEPT.

Retina (Philadelphia, Pa.)

Tan ACS, Jordan-Yu JM, Vyas CH, Gan ATL, Teo KYC, Chan CM, Mathur R, Wong TY, Chakravarthy U, Cheung GCM.
PMID: 34412103
Retina. 2022 Jan 01;42(1):114-122. doi: 10.1097/IAE.0000000000003285.

PURPOSE: To evaluate whether optical coherence tomography (OCT) can determine polypoidal lesion (PL) perfusion in polypoidal choroidal vasculopathy eyes after 12 months of aflibercept monotherapy. Polypoidal lesion perfusion status, assessed by indocyanine green angiography, is an important anatomical outcome...

Cite
Tan ACS, Jordan-Yu JM, Vyas CH, et al. OPTICAL COHERENCE TOMOGRAPHY FEATURES OF POLYPOIDAL LESION CLOSURE IN POLYPOIDAL CHOROIDAL VASCULOPATHY TREATED WITH AFLIBERCEPT. Retina. 2022;42(1):114-122doi: 10.1097/IAE.0000000000003285.
Tan, A. C. S., Jordan-Yu, J. M., Vyas, C. H., Gan, A. T. L., Teo, K. Y. C., Chan, C. M., Mathur, R., Wong, T. Y., Chakravarthy, U., & Cheung, G. C. M. (2022). OPTICAL COHERENCE TOMOGRAPHY FEATURES OF POLYPOIDAL LESION CLOSURE IN POLYPOIDAL CHOROIDAL VASCULOPATHY TREATED WITH AFLIBERCEPT. Retina (Philadelphia, Pa.), 42(1), 114-122. https://doi.org/10.1097/IAE.0000000000003285
Tan, Anna C S, et al. "OPTICAL COHERENCE TOMOGRAPHY FEATURES OF POLYPOIDAL LESION CLOSURE IN POLYPOIDAL CHOROIDAL VASCULOPATHY TREATED WITH AFLIBERCEPT." Retina (Philadelphia, Pa.) vol. 42,1 (2022): 114-122. doi: https://doi.org/10.1097/IAE.0000000000003285
Tan ACS, Jordan-Yu JM, Vyas CH, Gan ATL, Teo KYC, Chan CM, Mathur R, Wong TY, Chakravarthy U, Cheung GCM. OPTICAL COHERENCE TOMOGRAPHY FEATURES OF POLYPOIDAL LESION CLOSURE IN POLYPOIDAL CHOROIDAL VASCULOPATHY TREATED WITH AFLIBERCEPT. Retina. 2022 Jan 01;42(1):114-122. doi: 10.1097/IAE.0000000000003285. PMID: 34412103.
Copy Download .nbib Format: NLM
Atrial Fibrillation and Coronary Artery Disease: A Long-Term Perspective on the Need for Combined Antithrombotic Therapy.

Circulation. Cardiovascular interventions

Fanaroff AC, Li S, Marquis-Gravel G, Giri J, Lopes RD, Piccini JP, Wang TY.
PMID: 34932388
Circ Cardiovasc Interv. 2021 Dec;14(12):e011232. doi: 10.1161/CIRCINTERVENTIONS.121.011232. Epub 2021 Dec 21.

BACKGROUND: Older adults with atrial fibrillation (AF) are often treated with the shortest possible duration of antiplatelet/anticoagulant therapy after myocardial infarction (MI) or percutaneous coronary intervention (PCI) due to concern for bleeding. However, the risk of recurrent MI or...

Cite
Fanaroff AC, Li S, Marquis-Gravel G, et al. Atrial Fibrillation and Coronary Artery Disease: A Long-Term Perspective on the Need for Combined Antithrombotic Therapy. Circ Cardiovasc Interv. 2021;14(12):e011232doi: 10.1161/CIRCINTERVENTIONS.121.011232.
Fanaroff, A. C., Li, S., Marquis-Gravel, G., Giri, J., Lopes, R. D., Piccini, J. P., & Wang, T. Y. (2021). Atrial Fibrillation and Coronary Artery Disease: A Long-Term Perspective on the Need for Combined Antithrombotic Therapy. Circulation. Cardiovascular interventions, 14(12), e011232. https://doi.org/10.1161/CIRCINTERVENTIONS.121.011232
Fanaroff, Alexander C, et al. "Atrial Fibrillation and Coronary Artery Disease: A Long-Term Perspective on the Need for Combined Antithrombotic Therapy." Circulation. Cardiovascular interventions vol. 14,12 (2021): e011232. doi: https://doi.org/10.1161/CIRCINTERVENTIONS.121.011232
Fanaroff AC, Li S, Marquis-Gravel G, Giri J, Lopes RD, Piccini JP, Wang TY. Atrial Fibrillation and Coronary Artery Disease: A Long-Term Perspective on the Need for Combined Antithrombotic Therapy. Circ Cardiovasc Interv. 2021 Dec;14(12):e011232. doi: 10.1161/CIRCINTERVENTIONS.121.011232. Epub 2021 Dec 21. PMID: 34932388.
Copy Download .nbib Format: NLM
Tumor acidity-activatable photothermal/Fenton nanoagent for synergistic therapy.

Journal of colloid and interface science

Yang Z, Zhang L, Wei J, Li R, Xu Q, Hu H, Xu Z, Ren J, Wong CY.
PMID: 34998195
J Colloid Interface Sci. 2021 Dec 25;612:355-366. doi: 10.1016/j.jcis.2021.12.134. Epub 2021 Dec 25.

Intracellular formation of therapeutic agents has become one of the effective ways for cancer-specific treatment. Herein, a tumor acidity-activatable photothermal/Fenton nanoagent (denoted as CoPy) was constructed based on oxidized zeolitic imidazolate framework-67 (oxZIF-67) nanosheet and pyrrole (Py) monomer for...

Cite
Yang Z, Zhang L, Wei J, et al. Tumor acidity-activatable photothermal/Fenton nanoagent for synergistic therapy. J Colloid Interface Sci. 2021;612:355-366doi: 10.1016/j.jcis.2021.12.134.
Yang, Z., Zhang, L., Wei, J., Li, R., Xu, Q., Hu, H., Xu, Z., Ren, J., & Wong, C. Y. (2021). Tumor acidity-activatable photothermal/Fenton nanoagent for synergistic therapy. Journal of colloid and interface science, 612355-366. https://doi.org/10.1016/j.jcis.2021.12.134
Yang, Zhe, et al. "Tumor acidity-activatable photothermal/Fenton nanoagent for synergistic therapy." Journal of colloid and interface science vol. 612 (2021): 355-366. doi: https://doi.org/10.1016/j.jcis.2021.12.134
Yang Z, Zhang L, Wei J, Li R, Xu Q, Hu H, Xu Z, Ren J, Wong CY. Tumor acidity-activatable photothermal/Fenton nanoagent for synergistic therapy. J Colloid Interface Sci. 2021 Dec 25;612:355-366. doi: 10.1016/j.jcis.2021.12.134. Epub 2021 Dec 25. PMID: 34998195.
Copy Download .nbib Format: NLM
Retinal microvascular signs in COVID-19.

The British journal of ophthalmology

Sim R, Cheung G, Ting D, Wong E, Wong TY, Yeo I, Wong CW.
PMID: 33741583
Br J Ophthalmol. 2021 Mar 19; doi: 10.1136/bjophthalmol-2020-318236. Epub 2021 Mar 19.

BACKGROUND/AIMS: To explore if retinal findings are associated with COVID-19 infection.METHODS: In this prospective cross-sectional study, we recruited participants positive for COVID-19 by nasopharyngeal swab, with no medical history. Subjects underwent retinal imaging with an automated imaging device (3D...

Cite
Sim R, Cheung G, Ting D, et al. Retinal microvascular signs in COVID-19. Br J Ophthalmol. 2021;doi: 10.1136/bjophthalmol-2020-318236.
Sim, R., Cheung, G., Ting, D., Wong, E., Wong, T. Y., Yeo, I., & Wong, C. W. (2021). Retinal microvascular signs in COVID-19. The British journal of ophthalmology, . https://doi.org/10.1136/bjophthalmol-2020-318236
Sim, Ralene, et al. "Retinal microvascular signs in COVID-19." The British journal of ophthalmology vol. (2021). doi: https://doi.org/10.1136/bjophthalmol-2020-318236
Sim R, Cheung G, Ting D, Wong E, Wong TY, Yeo I, Wong CW. Retinal microvascular signs in COVID-19. Br J Ophthalmol. 2021 Mar 19; doi: 10.1136/bjophthalmol-2020-318236. Epub 2021 Mar 19. PMID: 33741583; PMCID: PMC7985973.
Copy Download .nbib Format: NLM
Retinal arteriolar calibre and venular fractal dimension predict progression of proliferative diabetic retinopathy 6 months after panretinal photocoagulation: a prospective, clinical interventional study.

BMJ open ophthalmology

Torp TL, Kawasaki R, Wong TY, Peto T, Grauslund J.
PMID: 33786381
BMJ Open Ophthalmol. 2021 Mar 22;6(1):e000661. doi: 10.1136/bmjophth-2020-000661. eCollection 2021.

OBJECTIVE: We examined the hypothesis that baseline retinal vascular geometry in patients with proliferative diabetic retinopathy (PDR) predicts disease activity 6 months after panretinal photocoagulation (PRP).METHODS AND ANALYSIS: We included 47 eyes from 40 patients with treatment-naïve PDR in...

Cite
Torp TL, Kawasaki R, Wong TY, et al. Retinal arteriolar calibre and venular fractal dimension predict progression of proliferative diabetic retinopathy 6 months after panretinal photocoagulation: a prospective, clinical interventional study. BMJ Open Ophthalmol. 2021;6(1):e000661doi: 10.1136/bmjophth-2020-000661.
Torp, T. L., Kawasaki, R., Wong, T. Y., Peto, T., & Grauslund, J. (2021). Retinal arteriolar calibre and venular fractal dimension predict progression of proliferative diabetic retinopathy 6 months after panretinal photocoagulation: a prospective, clinical interventional study. BMJ open ophthalmology, 6(1), e000661. https://doi.org/10.1136/bmjophth-2020-000661
Torp, Thomas Lee, et al. "Retinal arteriolar calibre and venular fractal dimension predict progression of proliferative diabetic retinopathy 6 months after panretinal photocoagulation: a prospective, clinical interventional study." BMJ open ophthalmology vol. 6,1 (2021): e000661. doi: https://doi.org/10.1136/bmjophth-2020-000661
Torp TL, Kawasaki R, Wong TY, Peto T, Grauslund J. Retinal arteriolar calibre and venular fractal dimension predict progression of proliferative diabetic retinopathy 6 months after panretinal photocoagulation: a prospective, clinical interventional study. BMJ Open Ophthalmol. 2021 Mar 22;6(1):e000661. doi: 10.1136/bmjophth-2020-000661. eCollection 2021. PMID: 33786381; PMCID: PMC7986874.
Copy Download .nbib Format: NLM
EBV+ posttransplant lymphoproliferative disease of the retina presenting as cytomegalovirus retinitis.

Annals of hematology

Wong IY, Ho WL, Iu LP, Lau KHP, Ho PL, Kwong YL.
PMID: 33009936
Ann Hematol. 2021 Dec;100(12):3061-3063. doi: 10.1007/s00277-020-04292-z. Epub 2020 Oct 03.

No abstract available.

Cite
Wong IY, Ho WL, Iu LP, et al. EBV+ posttransplant lymphoproliferative disease of the retina presenting as cytomegalovirus retinitis. Ann Hematol. 2020;100(12):3061-3063doi: 10.1007/s00277-020-04292-z.
Wong, I. Y., Ho, W. L., Iu, L. P., Lau, K. H. P., Ho, P. L., & Kwong, Y. L. (2021). EBV+ posttransplant lymphoproliferative disease of the retina presenting as cytomegalovirus retinitis. Annals of hematology, 100(12), 3061-3063. https://doi.org/10.1007/s00277-020-04292-z
Wong, Ian Y, et al. "EBV+ posttransplant lymphoproliferative disease of the retina presenting as cytomegalovirus retinitis." Annals of hematology vol. 100,12 (2021): 3061-3063. doi: https://doi.org/10.1007/s00277-020-04292-z
Wong IY, Ho WL, Iu LP, Lau KHP, Ho PL, Kwong YL. EBV+ posttransplant lymphoproliferative disease of the retina presenting as cytomegalovirus retinitis. Ann Hematol. 2021 Dec;100(12):3061-3063. doi: 10.1007/s00277-020-04292-z. Epub 2020 Oct 03. PMID: 33009936.
Copy Download .nbib Format: NLM
Response to the Comment on "The Risk of Going Small: Lowering GRWR and Overcoming Small-for-Size Syndrome in Adult Living Donor Liver Transplantation".

Annals of surgery

Wong TC, Lo CM.
PMID: 33201102
Ann Surg. 2021 Dec 01;274(6):e774-e775. doi: 10.1097/SLA.0000000000004441.

No abstract available.

Cite
Wong TC, Lo CM. Response to the Comment on "The Risk of Going Small: Lowering GRWR and Overcoming Small-for-Size Syndrome in Adult Living Donor Liver Transplantation". Ann Surg. 2021;274(6):e774-e775doi: 10.1097/SLA.0000000000004441.
Wong, T. C., & Lo, C. M. (2021). Response to the Comment on "The Risk of Going Small: Lowering GRWR and Overcoming Small-for-Size Syndrome in Adult Living Donor Liver Transplantation". Annals of surgery, 274(6), e774-e775. https://doi.org/10.1097/SLA.0000000000004441
Wong, Tiffany Cho-Lam, and Lo, Chung-Mau. "Response to the Comment on "The Risk of Going Small: Lowering GRWR and Overcoming Small-for-Size Syndrome in Adult Living Donor Liver Transplantation"." Annals of surgery vol. 274,6 (2021): e774-e775. doi: https://doi.org/10.1097/SLA.0000000000004441
Wong TC, Lo CM. Response to the Comment on "The Risk of Going Small: Lowering GRWR and Overcoming Small-for-Size Syndrome in Adult Living Donor Liver Transplantation". Ann Surg. 2021 Dec 01;274(6):e774-e775. doi: 10.1097/SLA.0000000000004441. PMID: 33201102.
Copy Download .nbib Format: NLM
ESL TEACHER CANDIDATES' PERCEPTIONS OF STRENGTHS AND INADEQUACIES OF INSTRUCTING CULTURALLY AND LINGUISTICALLY DIVERSE STUDENTS: POST CLINICAL EXPERIENCE.

Wong CY, Indiatsi J, Wong GK.
UIID-AD: 4423
2016;57-64.

The present case study examined English as a second language (ESL) teacher candidates' views on their preparedness on instructing culturally and linguistically diverse students. A survey was administrated to a group of ESL teacher candidates at the end of...

Cite
Wong CY, Indiatsi J, Wong GK. ESL TEACHER CANDIDATES' PERCEPTIONS OF STRENGTHS AND INADEQUACIES OF INSTRUCTING CULTURALLY AND LINGUISTICALLY DIVERSE STUDENTS: POST CLINICAL EXPERIENCE. 2016;57-64
Wong, C. Y., Indiatsi, J., & Wong, G. K. (2016). ESL TEACHER CANDIDATES' PERCEPTIONS OF STRENGTHS AND INADEQUACIES OF INSTRUCTING CULTURALLY AND LINGUISTICALLY DIVERSE STUDENTS: POST CLINICAL EXPERIENCE. 57-64.
Wong, C Y, et al. "ESL TEACHER CANDIDATES' PERCEPTIONS OF STRENGTHS AND INADEQUACIES OF INSTRUCTING CULTURALLY AND LINGUISTICALLY DIVERSE STUDENTS: POST CLINICAL EXPERIENCE." vol. (2016): 57-64.
Wong CY, Indiatsi J, Wong GK. ESL TEACHER CANDIDATES' PERCEPTIONS OF STRENGTHS AND INADEQUACIES OF INSTRUCTING CULTURALLY AND LINGUISTICALLY DIVERSE STUDENTS: POST CLINICAL EXPERIENCE. 2016;57-64. UIID-AD: 4423.
Copy Download .nbib Format: NLM
Showing 1465 to 1475 of 1475 entries